PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.71
ESG score 80-90% of SGMO's 64.23. Walter Schloss would scrutinize governance quality and regulatory exposure.
54.44
Environmental score below 80% of SGMO's 68.70. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
58.35
Social score 80-90% of SGMO's 66.46. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
57.34
Similar governance score to SGMO's 57.54. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.